Showing results (141-150 of 1,520) with videos related to
Sort By:
Pageof 152
CPT: Pharmacometrics & Systems Pharmacology|May 3, 2021
Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real-world Unified Parkinson's Disease Rating ScaleDongwoo Chae, Su Jin Chung, Phil Hyu Lee, et al.CPT: Pharmacometrics & Systems Pharmacology|May 6, 2021
Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonistsAndrea Henrich, Christian Hove Claussen, Jasper Dingemanse, et al.CPT: Pharmacometrics & Systems Pharmacology|August 16, 2021
Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic modelsVan Thuy Truong, Paul G Baverel, Grant D Lythe, et al.CPT: Pharmacometrics & Systems Pharmacology|May 1, 2021
Cytochrome P450 2D6 genotype-phenotype characterization through population pharmacokinetic modeling of tedatioxetineTrine Frederiksen, Johan Areberg, Ellen Schmidt, et al.CPT: Pharmacometrics & Systems Pharmacology|December 1, 2022
Mechanistic modeling of drug products applied to the skin: A workshop summary reportEleftheria Tsakalozou, Khondoker Alam, Priyanka Ghosh, et al.CPT: Pharmacometrics & Systems Pharmacology|June 7, 2022
Multi-phase multi-layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skinNikunjkumar Patel, James F Clarke, Farzaneh Salem, et al.CPT: Pharmacometrics & Systems Pharmacology|January 11, 2023
Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overviewAndrew Babiskin, Fang Wu, Youssef Mousa, et al.CPT: Pharmacometrics & Systems Pharmacology|December 24, 2022
Oncolytic viral kinetics mechanistic modeling of Talimogene Laherparepvec (T-VEC) a first-in-class oncolytic viral therapy in patients with advanced melanomaMalidi Ahamadi, Johannes Kast, Po-Wei Chen, et al.CPT: Pharmacometrics & Systems Pharmacology|January 24, 2023
Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adultsConor J O'Hanlon, Nick Holford, Anita Sumpter, et al.CPT: Pharmacometrics & Systems Pharmacology|June 22, 2021
Application of a dual mechanistic approach to support bilastine dose selection for older adultsChaejin Kim, Valentina Lo Re, Monica Rodriguez, et al.Pageof 152